Literature DB >> 2180939

Conantokin-T. A gamma-carboxyglutamate containing peptide with N-methyl-d-aspartate antagonist activity.

J A Haack1, J Rivier, T N Parks, E E Mena, L J Cruz, B M Olivera.   

Abstract

Conantokin-T, a 21-amino acid peptide which induces sleep-like symptoms in young mice was purified from the venom of the fish-hunting cone snail, Conus tulipa. The amino acid sequence of the peptide was determined and verified by chemical synthesis. The peptide has 4 residues of the modified amino acid, gamma-carboxyglutamate (Gla). The sequence of the peptide is: Gly-Glu-Gla-Gla-Tyr-Gln-Lys-Met-Leu-Gla-Asn-Leu-Arg-Gla-Ala-Glu-Val-Lys- Lys-Asn-Ala-NH2. Conantokin-T inhibits N-methyl-D-aspartate (NMDA) receptor-mediated calcium influx in central nervous system neurons. This observation suggests that like conantokin-G (a homologous Conus peptide with recently identified NMDA antagonist activity) conantokin-T has NMDA antagonist activity. A sequence comparison of conantokins-T and -G identifies the 4 Gla residues and the N-terminal dipeptide sequence as potential key elements for the biological activity of this peptide.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180939

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.

Authors:  Konkallu Hanumae Gowd; Tiffany S Han; Vernon Twede; Joanna Gajewiak; Misty D Smith; Maren Watkins; Randall J Platt; Gabriela Toledo; H Steve White; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Biochemistry       Date:  2012-05-30       Impact factor: 3.162

2.  A vasopressin/oxytocin-related conopeptide with gamma-carboxyglutamate at position 8.

Authors:  Carolina Möller; Frank Marí
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

3.  The effect of charge-charge interactions on the kinetics of alpha-helix formation.

Authors:  Deguo Du; Michelle R Bunagan; Feng Gai
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  Non-strict strand orientation of the Ca2+-induced dimerization of a conantokin peptide variant with sequence-shifted gamma-carboxyglutamate residues.

Authors:  Qiuyun Dai; Cai Xiao; Mingxin Dong; Zhuguo Liu; Zhenyu Sheng; Francis J Castellino; Mary Prorok
Journal:  Peptides       Date:  2009-01-24       Impact factor: 3.750

5.  gamma -Glutamyl carboxylation: An extracellular posttranslational modification that antedates the divergence of molluscs, arthropods, and chordates.

Authors:  Pradip K Bandyopadhyay; James E Garrett; Reshma P Shetty; Tyler Keate; Craig S Walker; Baldomero M Olivera
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

6.  Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.

Authors:  John Cheriyan; Rashna D Balsara; Kasper B Hansen; Francis J Castellino
Journal:  Neurosci Lett       Date:  2016-02-23       Impact factor: 3.046

7.  Conantokin-P, an unusual conantokin with a long disulfide loop.

Authors:  Konkallu Hanumae Gowd; Vernon Twede; Maren Watkins; K S Krishnan; Russell W Teichert; Grzegorz Bulaj; Baldomero M Olivera
Journal:  Toxicon       Date:  2008-06-03       Impact factor: 3.033

8.  Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities toward Ion Channels of N-Methyl-d-aspartate Receptors.

Authors:  Shailaja Kunda; Yue Yuan; Rashna D Balsara; Jaroslav Zajicek; Francis J Castellino
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

9.  Various conotoxin diversifications revealed by a venomic study of Conus flavidus.

Authors:  Aiping Lu; Longjin Yang; Shaoqiong Xu; Chunguang Wang
Journal:  Mol Cell Proteomics       Date:  2013-10-14       Impact factor: 5.911

Review 10.  Ligands for ionotropic glutamate receptors.

Authors:  Geoffrey T Swanson; Ryuichi Sakai
Journal:  Prog Mol Subcell Biol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.